Full Text
PCV86 COST-UTILITY ANALYSIS OF RIVAROXABAN COMPARED WITH ENOXAPARIN IN PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL HIP REPLACEMENT IN SLOVAKIA

Abstract

Authors

R Pereira A Diamantopoulos J Bielik M Lees D Tomek M Lukac

Back to Volume 13, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×